After years of hospital stays and fear, families are watching their kids thrive. Today, the gene therapy they received earned accelerated approval from the FDA.
Researchers report that all nine patients who were successfully treated for ADA-SCID in a UCLA clinical trial from 2009 to 2012 are still disease-free.